DiviDrip · NGNE

NGNE — Neurogene Inc.

NGNE is Neurogene Inc. (Healthcare) — a non-dividend-paying stock. Trading at $38.60. Market cap: $753M. Capital Quality Rank: 59/100 — Above average.

Stock snapshot

Price$38.60
Market cap$753M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)59 / 100 · Above average
ROIC (TTM)-13.9%
Shareholder buyback yield-17.63%
Altman Z-score zoneSafe

About NGNE

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Listed2023Employees131HQNew York, NYSectorHealthcareWebsiteneurogene.com

Related non-dividend companies

Other non-dividend stocks investors research alongside NGNE. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is NGNE's current stock price?

NGNE (Neurogene Inc.) is currently trading at $38.60.

Does NGNE pay a dividend?

NGNE (Neurogene Inc.) does not currently pay a regular dividend.

What is NGNE's Capital Quality Rank?

NGNE has a Capital Quality Rank of 59/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track NGNE in DiviDrip

Add NGNE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow